The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
GE Vernova GEV
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · GE Vernova Inc., an energy company, engages in the provision of various products and services that generate, transfer, orchestrate, convert, and store electricity in the United States, Europe, Asia, the Middle East, and Africa.
read at $1,014.75
GE Vernova holds its Distribution at $1,014.75.
- PHPhase · the trend structure carries the Distribution label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 23 days |
| Price | $1,014.75 |
| Valuation | 29.12 trailing · 41.09 forward price to earnings |
| Values screen | PASS · score 88.6 |
| Beta | 0.94 |
The opportunity · what the numbers say it is worth
Our framework reads OVERVALUED — it trades above our $871.93 fair value estimate, strong competitive moat, 21.90% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 21.90% |
| Profit margin | 23.04% |
| Debt to equity | 28.36 |
| Analyst consensus | Buy · 34 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 1.9% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 2.9% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 26.5% of assets, under the 49% limit. Pass
- Revenue purity Only 1.2% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Strong grid business priced for perfection
Picture every wind farm and gas turbine feeding the grid, and you see why GE Vernova commands attention. Revenue climbs 16 percent, profit margins sit at 24 percent and return on equity reaches 76 percent with a strong moat protecting the core power and electrification segments. Those numbers explain the buy ratings from 34 analysts.
Yet the shares trade at 43 times forward earnings, well above our fair value of 863 dollars while the current price sits at 1058 dollars. That leaves an 18 percent negative margin of safety even after the market has already baked in strong growth. High multiples on energy equipment rarely hold when cycles turn.
The main risk is simple overpayment. Energy transition spending can pause, input costs can spike and earnings multiples compress quickly in this sector. Paying up leaves little room for disappointment. Analysis, not advice.
| Forward P/E | 41.1x priced for continued growth |
| Trailing P/E | 29.1x a premium valuation |
| Revenue growth | 21.9% strong top-line growth |
| Profit margin | 23.0% healthy profit margins |
| Return on equity | 82.6% an exceptional return on shareholder capital |
| Debt to equity | 0.28 minimal debt — a conservative balance sheet |
| Current ratio | 0.85 below 1 — short-term bills exceed liquid assets |
| Beta | 0.94 steadier than the market |
| Market cap | $270.3B |
| Employees | 78,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on GEV
- › 3 Cash-Heavy Stocks Worth Your Attention StockStory · 2d ago
- › GE Vernova vs. NuScale Power: Which Industrials Stock Is a Better Buy in 2026? Motley Fool · 3d ago
- › Sector Update: Energy Stocks Higher Late Afternoon MT Newswires · 3d ago
- › GE HealthCare Stock Soars After Earnings—and It’s Suddenly the Best Performing GE Barrons.com · 4d ago
- › Vertiv Earnings Beat Estimates. Why the Stock Is Falling. Barrons.com · 4d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in GEV's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
GEV trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 13.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 44% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 85%. Our forward projection puts the odds of a 10% gain over the next month near 50%. The street (32 analysts) rates it buy, with a mean price target of $1217. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | POTVIN MATTHEW JOSEPH | Officer | 2,333 | $2,470,857 | |
| 2026-05-14 | REYNOLDS PAULA ROSPUT | Director | 495 | · | |
| 2026-05-14 | DONALD ARNOLD WAYNE | Director | 495 | · | |
| 2026-05-14 | HUND-MEJEAN MARTINA | Director | 495 | · | |
| 2026-05-14 | ANGEL STEPHEN F | Director | 1,350 | · | |
| 2026-05-14 | AKINS NICHOLAS K | Director | 495 | · | |
| 2026-05-14 | RUCKER KIM K. W. | Director | 495 | · | |
| 2026-05-14 | MALAVE JESUS JR. | Director | 495 | · | |
| 2026-05-14 | MATTHEW HARRIS C | Director | 495 | · | |
| 2026-04-27 | STRAZIK SCOTT | Chief Executive Officer | 44,496 | $5,353,535 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 16 Jun2026 | Matt Van Epps | Republican | sell | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1,073.08 | -20.0% | · | $800 | -20.0% |
| 2 months | $991.32 | -13.4% | · | $866 | -13.4% |
| 3 months | $831.61 | +3.2% | $0.50 | $1,032 | +3.2% |
| 6 months | $703.26 | +22.0% | $1.00 | $1,222 | +22.2% |
| 1 year | $464.29 | +84.8% | $1.50 | $1,851 | +85.1% |
| 2 years | $166.02 | +416.8% | $2.00 | $5,180 | +418.0% |
Historical returns from market close data. Past performance does not guarantee future results.